Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2020 4254.1% Revenue growth, 20204 Where the money goes Where each dollar of revenue went, fiscal 2020 Other costs
Cost of revenue 4¢ $22.5K Other costs 96¢ $481.0K Out of $503.5K in revenue.4 3
Where each dollar of operating cash went, fiscal 2020 Kept or used elsewhere
Kept or used elsewhere 100¢ $518.3K Out of $518.3K of cash from operations.3
Financial statements
Income statement Balance sheet Cash flow
Annual Quarterly
Revenue4 $503.5K in 2020+4254% since 2019 0 $200.0K $400.0K $600.0K 2019: $11.6K $11.6K 2019 2020: $503.5K $503.5K 2020 +4254% Operating income6 4 3 -$186.6K in 2020−91% since 2018 -$4.0M -$3.0M -$2.0M -$1.0M 0 2018: -$2.0M -$2.0M 2018 2019: -$3.4M -$3.4M 2019 +67% 2020: -$186.6K -$186.6K 2020 −95% Net income6 4 3 -$709.3K in 2020−84% since 2018 -$6.0M -$4.0M -$2.0M 0 2018: -$4.4M -$4.4M 2018 2019: -$4.9M -$4.9M 2019 +11% 2020: -$709.3K -$709.3K 2020 −86% Gross profit7 8 9 $0 in Q1 FY20240 $200.0K $400.0K $600.0K Q2 FY2024: $453.7K $453.7K Q2 FY2024 Q3 FY2024: $172.4K $172.4K Q3 FY2024 −62% Q1 FY2024: $0 $0 Q1 FY2024 Operating income7 8 9 -$447.9K in Q1 FY2024+897% since Q2 FY2024 -$600.0K -$400.0K -$200.0K 0 Q2 FY2024: -$44.9K -$44.9K Q2 FY2024 Q3 FY2024: -$332.7K -$332.7K Q3 FY2024 +640% Q1 FY2024: -$447.9K -$447.9K Q1 FY2024 +35% Net income7 8 9 -$1.3M in Q1 FY2024+682% since Q2 FY2024 -$1.5M -$1.0M -$500.0K 0 Q2 FY2024: -$166.1K -$166.1K Q2 FY2024 Q3 FY2024: -$166.1K -$166.1K Q3 FY2024 +0% Q3 FY2024: -$458.2K -$458.2K Q3 FY2024 +176% Q1 FY2024: -$1.3M -$1.3M Q1 FY2024 +183% Fiscal year 2018 2019 2020 Revenue $11.6K4 $503.5K4 Cost of revenue $22.5K3 Gross profit $481.0K3 Operating income -$2.0M6 -$3.4M4 -$186.6K3 Interest $2.3M10 Net income -$4.4M6 -$4.9M4 -$709.3K3 Earnings per share
Total assets6 4 3 $14.9M in 2020+57% since 2018 0 $5.0M $10.0M $15.0M 2018: $9.5M $9.5M 2018 2019: $11.8M $11.8M 2019 +24% 2020: $14.9M $14.9M 2020 +26% Total liabilities6 4 3 $9.0M in 2020+242% since 2018 0 $2.5M $5.0M $7.5M $10.0M 2018: $2.6M $2.6M 2018 2019: $5.7M $5.7M 2019 +115% 2020: $9.0M $9.0M 2020 +59% Shareholders’ equity4 3 5 $5.9M in 2020−14% since 2018 0 $2.0M $4.0M $6.0M $8.0M 2018: $6.8M $6.8M 2018 2019: $6.1M $6.1M 2019 −11% 2020: $5.9M $5.9M 2020 −4% Cash6 4 3 $183.0K in 2020−8% since 2018 0 $200.0K $400.0K $600.0K 2018: $198.1K $198.1K 2018 2019: $455.8K $455.8K 2019 +130% 2020: $183.0K $183.0K 2020 −60% Total assets7 8 9 $10.1M in Q1 FY2024−31% since Q2 FY2024 0 $5.0M $10.0M $15.0M Q2 FY2024: $14.8M $14.8M Q2 FY2024 Q3 FY2024: $14.3M $14.3M Q3 FY2024 −3% Q1 FY2024: $14.1M $14.1M Q1 FY2024 −2% Q1 FY2024: $10.1M $10.1M Q1 FY2024 −28% Total liabilities7 8 9 $7.0M in Q1 FY2024−26% since Q2 FY2024 0 $2.5M $5.0M $7.5M $10.0M Q2 FY2024: $9.4M $9.4M Q2 FY2024 Q3 FY2024: $9.4M $9.4M Q3 FY2024 −0% Q1 FY2024: $9.6M $9.6M Q1 FY2024 +2% Q1 FY2024: $7.0M $7.0M Q1 FY2024 −27% Shareholders’ equity7 8 9 $3.2M in Q1 FY2024−41% since Q2 FY2024 0 $2.0M $4.0M $6.0M Q2 FY2024: $5.4M $5.4M Q2 FY2024 Q3 FY2024: $5.4M $5.4M Q3 FY2024 +0% Q3 FY2024: $4.9M $4.9M Q3 FY2024 −9% Q1 FY2024: $4.5M $4.5M Q1 FY2024 −9% Q1 FY2024: $3.2M $3.2M Q1 FY2024 −29% Cash7 8 9 $131.2K in Q1 FY2024−74% since Q2 FY2024 0 $200.0K $400.0K $600.0K Q2 FY2024: $513.4K $513.4K Q2 FY2024 Q3 FY2024: $210.6K $210.6K Q3 FY2024 −59% Q1 FY2024: $48.8K $48.8K Q1 FY2024 −77% Q1 FY2024: $131.2K $131.2K Q1 FY2024 +169% Fiscal year 2018 2019 2020 Cash $198.1K6 $455.8K4 $183.0K3 Current assets $4.1M6 $1.4M4 $357.4K3 Total assets $9.5M6 $11.8M4 $14.9M3 Current liabilities $844.8K6 $781.3K4 $589.6K3 Total liabilities $2.6M6 $5.7M4 $9.0M3 Shareholders’ equity $6.8M4 $6.1M3 $5.9M5 Shares outstanding 22.1M shares6 23.5M shares6 23.7M shares4
Cash from operations6 4 3 $518.3K in 2020-$3.0M -$2.0M -$1.0M 0 $1.0M 2018: -$2.4M -$2.4M 2018 2019: -$2.2M -$2.2M 2019 −9% 2020: $518.3K $518.3K 2020 Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Fiscal year 2018 2019 2020 Cash from operations -$2.4M6 -$2.2M4 $518.3K3 Capital spending Free cash flow Share buybacks
Compare AmeriCann, Inc. with another company
Former names
Nevada Health Scan, Inc. Dec 23, 2010 to May 15, 20142
Recent filings
Mar 24, 2025 4 PRIMARY DOCUMENTFeb 14, 2025 10-Q Jan 15, 2025 10-K Dec 13, 2024 8-K Aug 28, 2024 8-K Aug 26, 2024 8-K Aug 12, 2024 10-Q May 14, 2024 10-Q May 7, 2024 8-K Feb 14, 2024 10-Q Dec 22, 2023 10-K Dec 11, 2023 8-K Aug 14, 2023 10-Q Aug 1, 2023 8-K May 11, 2023 10-Q Every filing from the last three years, summarized . The full record is on SEC EDGAR.1
